Snapshot from Jul 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / OKYO Pharma at Piper Sandler Symposium
Business conference participation

OKYO Pharma at Piper Sandler Symposium

Analysis based on 6 articles · First reported Jul 07, 2026 · Last updated Jul 07, 2026

Sentiment
0
Attention
0
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

This event is a routine investor relations activity with minimal direct market impact. It may provide a platform for OKYO Pharma to update investors on its clinical progress, but no material financial or operational changes are expected.

biotechnology ophthalmology
Event Summary

OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing therapies for neuropathic corneal pain (NCP) and anterior segment eye diseases, announced its participation in the Piper Sandler Companies Virtual Ophthalmology Symposium on July 9, 2026. The company's CEO Robert Dempsey and CMO Flavio Mantelli will present, with Biren Amin of Piper Sandler Companies moderating. OKYO recently completed a successful Phase 2 trial of urcosimod for NCP and plans to initiate a Phase 2b/3 study in the first half of 2026.

Key Actions
20 OKYO Pharma announced participation
Entities Involved
stock
OKYO Pharma
OKYO Pharma is the subject of the announcement, participating in the symposium to present its clinical developments.
Importance 100.0 Sentiment 0.0
stock
Piper Sandler Companies
Piper Sandler Companies is hosting the symposium and providing a platform for OKYO Pharma to present.
Importance 30.0 Sentiment 0.0
per
Robert Dempsey
CEO of OKYO Pharma, presenting at the symposium.
Importance 20.0 Sentiment 0.0
per
Flavio Mantelli
Chief Medical Officer of OKYO Pharma, presenting at the symposium.
Importance 20.0 Sentiment 0.0
per
Biren Amin
Managing Director at Piper Sandler Companies, moderating the fireside chat.
Importance 10.0 Sentiment 0.0
exch
Nasdaq
Nasdaq is the exchange where OKYO Pharma's shares are listed; no direct impact from this event.
Importance 5.0 Sentiment 0.0
Relationships
OKYO Pharma related ↔ Flavio Mantelli
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.